Product correctly added to cart.

discount label
Flupyrimin-d4
View 3D

Biosynth logo

Flupyrimin-d4

CAS: 1689566-03-7

Ref. 3D-PSC56603

10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 18 Feb 2025

Product Information

Name:
Flupyrimin-d4
Description:

Flupyrimin-d4 is a potent protein kinase inhibitor that has shown promising results in anticancer research. It is an analog of Flupyrimin, which has been used as a medicinal compound for treating various diseases. Flupyrimin-d4 has been found to induce apoptosis in cancer cells and inhibit the activity of kinases, which are enzymes that play a crucial role in cell signaling pathways. Studies have shown that Flupyrimin-d4 is effective against various types of cancer, including human bladder and lung cancer. This drug can be detected in urine samples, making it a useful tool for monitoring treatment efficacy. The Chinese have also used Flupyrimin-d4 as a traditional medicine for treating tumors. With its potential as an anticancer agent, Flupyrimin-d4 holds promise for the development of novel cancer therapies.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
315.68 g/mol
Formula:
C13H9ClF3N3O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-PSC56603 Flupyrimin-d4

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".